Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.

Saved in:
Bibliographic Details
Title: Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.
Authors: Lode H (AUTHOR), File TM Jr. (AUTHOR), Mandell L (AUTHOR), Ball P (AUTHOR), Pypstra R (AUTHOR), Thomas M (AUTHOR), 185 Gemifloxacin Study Group (CORPORATE AUTHOR)
Source: Clinical Therapeutics. Nov2002, Vol. 24 Issue 11, p1915-1936. 22p.
Database: Academic Search Ultimate
Description
ISSN:01492918
DOI:10.1016/s0149-2918(02)80088-1